Sign In
Buy CERS
$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
Cerus Corporation's (CERS) CEO Obi Greenman on Q4 2020 Results - Earnings Call Transcript
07:52pm, Thursday, 25'th Feb 2021
Cerus Corporation's (CERS) CEO Obi Greenman on Q4 2020 Results - Earnings Call Transcript
Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
08:30am, Thursday, 11'th Feb 2021
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full year 2020 financial results will be released on Thursday, February 25, 2021, after t
Cerus Update: Tailwinds Now Include FDA Approval Of Cryoprecipitate Product
09:59am, Wednesday, 16'th Dec 2020
Cerus' FDA & CE approved Intercept pathogen reduction platform for platelets and plasma gathering momentum as FDA Guidelines require compliance with new blood safety measures by March 31, 2021. Cerus'
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced that its distribution partner, Companhia Energética Integrada (CEI), was awarded a three-year contract with the Hemo
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced the oral presentation of a clinical study: “Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patie
Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Cryoprecipitation
08:30am, Monday, 30'th Nov 2020
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced that the US Food and Drug Administration (FDA) has granted approval of the INTERCEPT Blood System for Cryoprecipitati
Cerus Corporation (CERS) CEO Obi Greenman on Q3 2020 Results - Earnings Call Transcript
10:41pm, Thursday, 29'th Oct 2020
Cerus Corporation (CERS) CEO Obi Greenman on Q3 2020 Results - Earnings Call Transcript
Cerus Co. (NASDAQ:CERS) Shares Purchased by Raymond James Trust N.A.
05:46am, Tuesday, 20'th Oct 2020
Raymond James Trust N.A. boosted its position in Cerus Co. (NASDAQ:CERS) by 18.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 65,000 shares
Cerus Corporation to Release Third Quarter 2020 Financial Results on October 29, 2020
12:00am, Monday, 19'th Oct 2020
Cerus Corporation (Nasdaq:CERS) announced today that its third quarter 2020 financial results will be released on Thursday, October 29, 2020, after th
Cerus Inks FDA Contract, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:CERS)
07:29am, Friday, 16'th Oct 2020
Cerus Corporation inks FDA contract for Pathogen Reduction technology. Twist Biosciences strikes new deal for T Cell therapies.
Worldwide Industry for Blood Transfusion Diagnostics to 2027 - Strategic Recommendations for New Entrants - ResearchAndMarkets.com
12:00am, Tuesday, 13'th Oct 2020
The
Global Neurovascular Devices Market to Surpass US$ 3,180.7 Million by 2027, Says Coherent Market Insights (CMI)
12:00am, Friday, 09'th Oct 2020
North America is expected to be the most lucrative region in the neurovascular devices market due to the increasing prevalence of stroke.
The Evolution of Diagnostic Capabilities Underscores the Fight Against Viral Infections
01:00pm, Thursday, 08'th Oct 2020
NEW YORK, Oct. 8, 2020 /PRNewswire via COMTEX/ --
NEW YORK, Oct. 8, 2020 /PRNewswire/ -- Diagnostic tests are usually conducted in laboratories, private or...
Cerus Co. (NASDAQ:CERS) Shares Acquired by Two Sigma Advisers LP
07:56am, Thursday, 08'th Oct 2020
Two Sigma Advisers LP increased its stake in Cerus Co. (NASDAQ:CERS) by 145.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 105,000 shares of the b
